These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34771087)

  • 1. Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy.
    Wang M; Hou S; Liu Y; Li D; Lin J
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking.
    Wang M; Hou S; Wei Y; Li D; Lin J
    PLoS Comput Biol; 2021 Mar; 17(3):e1008821. PubMed ID: 33739970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacoinformatic approach on Cannabinoid receptor 2 (CB2) and different small molecules: Homology modelling, molecular docking, MD simulations, drug designing and ADME analysis.
    Vijayakumar S; Manogar P; Prabhu S; Pugazhenthi M; Praseetha PK
    Comput Biol Chem; 2019 Feb; 78():95-107. PubMed ID: 30500557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.
    Floresta G; Apirakkan O; Rescifina A; Abbate V
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation.
    Stasiulewicz A; Lesniak A; Bujalska-Zadrożny M; Pawiński T; Sulkowska JI
    J Chem Inf Model; 2023 Feb; 63(3):1012-1027. PubMed ID: 36693026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new potent A
    Wei Y; Wang M; Li Y; Hong Z; Li D; Lin J
    Eur J Med Chem; 2020 Feb; 187():111936. PubMed ID: 31855793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference and Influence of Inactive and Active States of Cannabinoid Receptor Subtype CB2: From Conformation to Drug Discovery.
    Hu J; Feng Z; Ma S; Zhang Y; Tong Q; Alqarni MH; Gou X; Xie XQ
    J Chem Inf Model; 2016 Jun; 56(6):1152-63. PubMed ID: 27186994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor.
    Salo OM; Raitio KH; Savinainen JR; Nevalainen T; Lahtela-Kakkonen M; Laitinen JT; Järvinen T; Poso A
    J Med Chem; 2005 Nov; 48(23):7166-71. PubMed ID: 16279774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators.
    Yuan J; Jiang C; Wang J; Chen CJ; Hao Y; Zhao G; Feng Z; Xie XQ
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities.
    Alqarni M; Myint KZ; Tong Q; Yang P; Bartlow P; Wang L; Feng R; Xie XQ
    Biochem Biophys Res Commun; 2014 Sep; 452(3):334-9. PubMed ID: 25148941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands.
    Ragusa G; Bencivenni S; Morales P; Callaway T; Hurst DP; Asproni B; Merighi S; Loriga G; Pinna GA; Reggio PH; Gessi S; Murineddu G
    ChemMedChem; 2018 Jun; 13(11):1102-1114. PubMed ID: 29575721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists.
    Pandey P; Roy KK; Liu H; Ma G; Pettaway S; Alsharif WF; Gadepalli RS; Rimoldi JM; McCurdy CR; Cutler SJ; Doerksen RJ
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30322136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
    Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The agonist binding mechanism of human CB2 receptor studied by molecular dynamics simulation, free energy calculation and 3D-QSAR studies.
    Chen JJ; Han S; Cao Y; Chen JZ
    Yao Xue Xue Bao; 2013 Sep; 48(9):1436-49. PubMed ID: 24358778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel agonists and antagonists of the ecdysone receptor by virtual screening.
    Hu X; Yin B; Cappelle K; Swevers L; Smagghe G; Yang X; Zhang L
    J Mol Graph Model; 2018 May; 81():77-85. PubMed ID: 29529496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPCR structure-based virtual screening approach for CB2 antagonist search.
    Chen JZ; Wang J; Xie XQ
    J Chem Inf Model; 2007; 47(4):1626-37. PubMed ID: 17580929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
    Sharma A; Thelma BK
    J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.